Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. - Wikidata - awgldk - TriplyDB

Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.

Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.

http://www.wikidata.org/entity/Q51720903

about

Functional analysis of colonic bacterial metabolism: relevant to health?Implication of fructans in health: immunomodulatory and antioxidant mechanisms Catabolism and biotechnological applications of cholesterol degrading bacteria.Consecutive Intake of Fermented Milk Containing Bifidobacterium breve Strain Yakult and Galacto-oligosaccharides Benefits Skin Condition in Healthy Adult Women.'Gut health': a new objective in medicine?Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores.Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.The colon: an overlooked site for therapeutics in dialysis patients.The bifidogenic effect of inulin and oligofructose and its consequences for gut health.Towards microbial fermentation metabolites as markers for health benefits of prebiotics.Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin.Short- and long-term dynamics in the intestinal microbiota following ingestion of Bifidobacterium animalis subsp. lactis GCL2505 Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients.Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis.Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial.Genes and molecules of lactobacilli supporting probiotic action.Bisphenol a in chronic kidney disease.Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic Novel Combination of Prebiotics Galacto-Oligosaccharides and Inulin-Inhibited Aberrant Crypt Foci Formation and Biomarkers of Colon Cancer in Wistar Rats.The effect of a commercial probiotic drink containing Lactobacillus casei strain Shirota on oral health in healthy dentate people.Biofluid metabotyping of occupationally exposed subjects to air pollution demonstrates high oxidative stress and deregulated amino acid metabolism.Molecular identification and phylogenetic analysis of Lactobacillus and Bifidobacterium spp. isolated from gut of honeybees (Apis mellifera) from West Azerbaijan, Iran.p-Cresyl Sulfate.Relevance of protein fermentation to gut health.Biotechnological approaches for the production of prebiotics and their potential applications.Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.The intestine and the kidneys: a bad marriage can be hazardous.Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism.Multilocus sequence typing of Lactobacillus casei reveals a clonal population structure with low levels of homologous recombination.Effect of Bifidobacterium animalis subsp. lactis GCL2505 on the physiological function of intestine in a rat model The metabolic effect of resistant starch and yoghurt on the renal and faecal nitrogen and ammonia excretion in humans as measured by lactose-[(15)N2]ureide.Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases.The food additives inulin and stevioside counteract oxidative stress

P2860

Q26851969-879B4557-1977-49AA-AA0B-322808DFC768 Q28084064-55C182E5-09C0-432A-B55E-8441FEB58793 Q30443155-47049207-BFD0-41C5-AADE-384B05DB7E0B Q33665964-596E1A33-AAB8-4894-9799-78A5C92A96F8 Q33845395-E0E623E4-96DD-4086-AD1D-432EFDF2CBCA Q33998828-AF301A02-24B6-43B4-A9DB-DEA1A984E11A Q34031430-ED1F1429-FB8C-4D9E-B201-BE2D6B9A4445 Q34588415-F75635A9-498B-4CF6-9D42-34BDC31C1207 Q34607428-FD5CE21D-C3A0-47DC-823C-7220BAE8E453 Q34610917-8E1C0E1A-335E-4839-944B-AD2DE30C4091 Q35686508-F28225B7-F99A-4D0A-8F28-4AE5682E91C7 Q35900047-C90F849E-2FA1-4EB6-BE6C-F7E558241872 Q36014389-6D1DBEC5-B95D-43D3-AF62-3DF79F7405C8 Q36076067-14AAEE5F-FC16-42A6-B155-2D27423B2610 Q36265114-81A83004-DD1F-411F-B79B-E1CD51E65517 Q36283056-3ACE402A-519E-4742-BFF2-6918E1235DB3 Q36506615-A1856DE9-E63E-41FD-965A-98A2179FA326 Q36579696-5D359052-1779-4225-8B32-C4E162002FDC Q36995291-06B58990-E33F-4626-B569-0781407F8E22 Q37127197-43A822B4-014A-4774-A6C1-27174B172FFA Q37161945-84488F0D-74A3-4744-A8E4-D899AF183B6B Q37202642-4425559F-8211-47A6-BDE9-0664450B0323 Q37269662-696BD73B-A18A-41A8-88B2-2335FEEC235A Q37355428-8CE83FEF-4A77-4CDC-AA58-53A499C2E11E Q37597330-15E376C7-98A8-455E-ABE8-B085CC38DE45 Q37672982-89884F60-5BFA-4927-8F8A-87EE5C53F386 Q37961650-7A44AD7D-98A4-461E-923F-AF04307A58FA Q38044031-657904A1-69F3-4E87-8F61-F4C4E2E5ACA4 Q38190366-10A1B071-2770-4BC0-A687-C7D87D619D5C Q38393212-1E581E93-56E0-4EE0-A131-06DCE7F9EE6F Q39906005-A03526CD-4F57-484B-B7AF-94E2277564D2 Q40007080-D31435C1-3D2F-41BB-9392-50C56A75EAF4 Q41646674-FEAC5046-A0A7-4493-BA8D-9057A082387F Q43496078-E634269E-CED0-484B-AC69-6973B8A66555 Q49348632-105C6EA9-21CF-4FB3-BC5F-AA9E34ADF2FD Q57260129-9677F88E-6632-4F0B-B2B2-468437F5AB30

P2860

Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans.

http://www.wikidata.org/entity/Q51720903

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@en

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@nl

type

label

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@en

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@nl

prefLabel

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@en

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@nl

P1433

Q51720903-1A92388C-DD8A-42B9-BCAC-CBC5E683BF45

P1476

Q51720903-8A3E15D8-C876-4362-876A-1068737FF628

P2093

Q51720903-1FA317E3-7790-484F-81A2-2B45C33E3FA5

Q51720903-9FF3DACE-866F-4DE3-AC65-238E28325E81

Q51720903-BF8AE6C1-4D81-4FD9-97AC-443B447679EB

Q51720903-E5546DB7-C8C4-446D-B010-2C56714C2544

Q51720903-EAFD0407-4A4D-402A-9D43-7A7D5250B216

P2860

Q51720903-03A645E7-68C3-4823-B735-F52CEEC2404B

Q51720903-0C482749-AB91-4E06-953E-B13EC3E2C9CA

Q51720903-184176C9-80FD-4CBA-8A34-5A63797235BE

Q51720903-1AD1D9E5-0FFB-4A8A-8B66-7256F1F6D9E5

Q51720903-3565616F-8F76-4B51-9280-74C372F0A52A

Q51720903-40125CD8-4C09-4279-BA6D-2CC7F75BAF52

Q51720903-402B3FAB-D23F-4897-BD02-5403E600C18F

Q51720903-62B8E0AD-A674-4F43-97BE-656190829C61

Q51720903-64FCB10B-3658-4562-A8D3-3771FA5BD155

Q51720903-656D7A35-3725-44EC-B40C-71162F2C7789

P304

Q51720903-8FB8EBD7-0B33-42E9-945D-4B6B482C0351

P31

Q51720903-DA673812-B4C3-47EA-B3F0-4D8E51A49253

P356

Q51720903-EEDC31E8-1431-4A13-AA92-2966415D8A61

P433

Q51720903-769404A6-0025-48B8-8DF0-4C321AC78B49

P478

Q51720903-EE52FABA-4225-4533-955F-D70EE371CD7A

P50

Q51720903-98A915BC-A416-45FE-AE36-CB4A942C0ADD

Q51720903-E8EC136C-8582-4785-A66F-B266A5D1E0FE

P577

Q51720903-C9FD6FB4-A783-433B-97A7-A8A4A380090B

P5875

Q51720903-4E444845-C98D-40D5-9D51-6B29A2C4FD7B

P698

Q51720903-39FE76B2-24BA-43E7-8001-CC18B27B9766

P356

AJPGI.00052.2006

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Effects of Lactobacillus casei ...... metabolism in healthy humans.

@en

P2093

Jean Swings

http://www.w3.org/2001/XMLSchema#string

Kristin Verbeke

http://www.w3.org/2001/XMLSchema#string

Luc De Vuyst

http://www.w3.org/2001/XMLSchema#string

Tom Vanhoutte

http://www.w3.org/2001/XMLSchema#string

Vicky De Preter

http://www.w3.org/2001/XMLSchema#string

P2860

Probiotics in human medicine.

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

The microbial contribution to human faecal mass

Rapid quality control analysis of (13)C-enriched substrate synthesis by isotope ratio mass spectrometry.

Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids.

Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel.

Abnormal colonic fermentation in irritable bowel syndrome.

Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers.

Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces.

PASSCLAIM--gut health and immunity.

P304

G358-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00052.2006

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

292

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6804919

http://www.w3.org/2001/XMLSchema#string

P698

16990449

http://www.w3.org/2001/XMLSchema#string